SCHEMBL2826080

SCHEMBL2826080

ClP(C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.38
GRIN3B O60391 5/20 0.38
GRIN1 Q05586 5/20 0.38
GRIN2A Q12879 5/20 0.38
GRIN2B Q13224 5/20 0.38
GRIN2C Q14957 5/20 0.38
GRIN3A Q8TCU5 5/20 0.38
LMNA P02545 2/20 0.38
SLC22A2 O15244 2/20 0.38
SLC47A1 Q96FL8 2/20 0.38
SLC22A1 O15245 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
STAT6 P42226 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
POLB P06746 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27623041 0.81 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1877773 0.73 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3840062 0.71 GRIN2D (0.32) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1456436 0.71
SCHEMBL5333489 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3842499 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL21873554 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5463104 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1092580 0.69 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30307624 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119391362-A High-temperature-resistant single-component silicone adhesive and preparation method thereof 佛山市科菱斯科技有限公司 2025-02-07 CN claimed
WO-2024219367-A1 METHOD FOR PRODUCING ARYLDIADAMANTYLPHOSPHINE DERIVATIVES AND METHOD FOR PRODUCING ARYLDIADAMANTYLPHOSPHONIUM SALT DERIVATIVES 日本化学工業株式会社 2024-10-24 WO claimed
CN-117801691-B Anti-precipitation EPE co-extrusion packaging adhesive film 苏州易昇光学材料股份有限公司 2024-06-18 CN claimed
CN-117801691-A Anti-precipitation EPE co-extrusion packaging adhesive film 苏州易昇光学材料股份有限公司 2024-04-02 CN claimed
CN-115850330-A Synthesis method of n-butyl di (1-adamantyl) phosphine 河南省科学院化学研究所有限公司 2023-03-28 CN claimed
CN-113999262-B Preparation method of di (1-adamantyl) cycloalkylphosphine ligand 苏州欣诺科生物科技有限公司 2022-03-29 CN claimed
CN-113999262-A Preparation method of di (1-adamantyl) cycloalkylphosphine ligand 苏州欣诺科生物科技有限公司 2022-02-01 CN claimed
EP-4688799-A1 CYCLOPENTADIENYL DERIVATIVES AND THEIR USES IN CATALYSIS Sigma-Aldrich Co., LLC (US) 2026-02-11 EP disclosed
EP-4665738-A1 MIXED P,N-DONOR LIGANDS, THEIR COMPLEXES AND USE THEREOF Umicore AG & Co. KG (DE) 2025-12-24 EP disclosed
US-20250368598-A1 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES BHATTACHARYA SHRABANTI (US) 2025-12-04 US disclosed
CN-119998255-A Catalytic carboxycarbonylation of olefins to form anhydrides 北卡罗来纳大学教堂山分校 2025-05-13 CN disclosed
US-12291489-B2 Synthesis of nanocomposites and their use in enhancing plant nutrition WASHINGTON UNIVERSITY (US) 2025-05-06 US disclosed
EP-4543841-A2 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES The University of North Carolina at Chapel Hill (US) 2025-04-30 EP disclosed
EP-1303525-A1 PRODUCTION OF NOVEL PHOSPHANE LIGANDS AND USE IN CATALYTICAL REACTIONS Degussa AG (DE) 2003-04-23 EP disclosed
US-20020156295-A1 Ligands for metals and improved metal-catalyzed processes based thereon NATIONAL SCIENCE FOUNDATION 2002-10-24 US disclosed
WO-2002055528-A1 NOVEL N-PHENYL-PYRROL BISPHOSPHANE COMPOUNDS AND THE METAL COMPLEXES OF THE SAME OXENO OLEFINCHEMIE GMBH (DE) 2002-07-18 WO disclosed
WO-2002010178-A1 ADAMANTYL GROUPS CONTAINING PHOSPHANE LIGANDS, THE PRODUCTION AND USE THEREOF IN CATALYTICAL REACTIONS DEGUSSA AG (DE) 2002-02-07 WO disclosed
US-6307087-B1 USE OF CATALYSTS COMPRISING THESE LIGANDS IN TRANSITION METAL-CATALYZED CARBON-HETEROATOM AND CARBON-CARBON BOND-FORMING REACTIONS. MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2001-10-23 US disclosed
EP-1097158-A2 LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-05-09 EP disclosed
WO-2000002887-A2 LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2000-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368598-A1 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES CA4, CA12, CA14 GRIN2D 3701/4885GRIN3B 3320/4885GRIN1 2864/4885
US-20020156295-A1 Ligands for metals and improved metal-catalyzed processes based thereon THEM6, SOD1, SLC30A6 GRIN2D 3845/4885GRIN3B 1267/4885GRIN1 2328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.